Tech Company Financing Transactions
Adynxx Funding Round
Private investors participated in a $4.8 million Series A capital raise for Adynxx. The round was recorded on 12/27/2010.
Transaction Overview
Company Name
Announced On
12/27/2010
Transaction Type
Venture Equity
Amount
$4,803,858
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Pine St. 500
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Website
Email Address
Overview
The company is dedicated to developing the next breakthrough therapeutic treatments for chronic pain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Orr
Chief Medical Officer
Donald Manning
Chief Scientific Officer
Julien Mamet
Controller
Dina Gonzalez
VP - Operations
William Martin
VP - Regulatory Affairs
Scott Harris
Browse more venture capital transactions:
Prev: 12/24/2010: Zumbox venture capital transaction
Next: 12/27/2010: Onset Medical venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs